![](https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/cd9c47364857a0746a3c70d70349c04225ed62d0-8000x6000.jpg?fit=crop&auto=format)
Targeting DLL3 in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
Précis DLL3 is an emerging therapeutic target in small cell lung cancer and other neuroendocrine carcinomas, with 1 FDA-approved therapy and several others under investigation. Abstract Small cell lung cancer (SCLC) is an aggressive neuroendocrine …